South Boston, MA, United States of America

Anna J Zoltoski

This inventor holds 2 USPTO granted patents and 4 EPO patents. Top assignee: Archemix Corporation. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna J Zoltoski. Retrieved from https://idiyas.com/inventor/anna-j-zoltoski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Anna J Zoltoski

Introduction: Anna J Zoltoski is a prominent inventor based in South Boston, MA, whose contributions to the field of therapeutics have garnered significant attention. With a total of two patents, she is at the forefront of developing innovative solutions for complex medical conditions.

Latest Patents: Zoltoski's latest patents focus on the development of aptamer therapeutics that are particularly useful in the treatment of complement-related disorders. These inventions provide nucleic acid therapeutics and outline methods for utilizing these nucleic acids in addressing specific health challenges associated with the complement system.

Career Highlights: Throughout her career, Anna J Zoltoski has demonstrated exceptional expertise in the area of nucleic acid therapeutics. Her role at Archemix Corporation underscores her commitment to advancing medical science and improving patient outcomes through innovative research.

Collaborations: Collaborating with talented individuals such as Claude Benedict and John Louis Diener, Zoltoski has been able to combine her knowledge with the insights of her colleagues, leading to groundbreaking advancements in the field of therapeutics.

Conclusion: Anna J Zoltoski’s work exemplifies the spirit of innovation that drives the medical therapeutics industry forward. Her contributions not only reflect her own dedication to invention but also highlight the importance of collaboration in achieving great strides in health-related innovations. With her continued efforts, the future looks promising for advancements in the treatment of complement-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…